Journal
GENETICS IN MEDICINE
Volume 16, Issue 7, Pages 504-509Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/gim.2013.186
Keywords
Association for Molecular PathOlogy v. Myriad; Genetics; CLIA; data aharing; genetic -databaSes; gene patents; HIPAA; innovation policy
Categories
Funding
- Greenwall Foundation
- University of Houston Law Foundation
- National Institutes of Health [U01HG006507, U01HG007307]
Ask authors/readers for more resources
The Supreme Courts recent decision in Association for Moiecu, lar Pathology v. Myriad Genetics portrays the- human genome as a product of nature. This frames medical genetics aS an eXtrac. tive industry that -mines a natural resource to produce valuable goods and services. Natural resource law offers insights into; problems medical geneticists can eXpect after this decision and suggests possible -sOlutions. Increased competition among,clini..cal laboratories offers various benefits but threatens to increase fragmentation of genetic data resources, potentially causing Waste in the form of lost opportunities to discover the clinical significance of particular gene variants. The solution lies in addressing, legal barriers to appropriate -data Sharing. Sustainable discovery in the field of medical genetics can best be achieved through' Voluntary data sharing rather than command-and-control tactics, but voluntary mechanisms must be conceived broadly to include Market-based approaches as well as,donative and publicly funded; data commons. They recently revised Health Insurance Portabil:ity and Accountability Act Privacy Rule offers an improved but still imperfect framework for market-oriented data sharing. This article explores strategies for addressing the Privacy Rule's remaining defects. America is close to having a legal framework that can reward innovators, proteet,privacy, and-promote needed data sharing to advance medical genetics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available